Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Host transcriptional response to TB preventive therapy differentiates two sub-groups of IGRA-positive individuals.
Broderick, C; CLIFF, JM; LEE, J-S; Kaforou, M; MOORE, DA;
2020
Tuberculosis, (2020).127, 10.1016/j.tube.2020.102033.
Corrigendum to "Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme" [Int. J. Infect. Dis. 97 (2020) 182-189].
Fariñas, AG; Linares-Pérez, N; CLARK, A; Toledo-Romaní, ME; Omeiri, NE; Araújo, MC M; Luis, IP G; Peraza, GT; Jiménez, AR; Ambrón, LL; Cuban Pneumococcal Vaccine Working Group,;
2020
International Journal of Infectious Diseases, (2020).103, 10.1016/j.ijid.2020.08.072.
The impact of the rotavirus vaccine on diarrhoea, five years following national introduction in Fiji.
Jenney, AW J; Reyburn, R; Ratu, FT; Tuivaga, E; Nguyen, C; Covea, S; Thomas, S; Rafai, E; Devi, R; Bright, K; Jenkins, K; Temple, B; Tikoduadua, L; Kado, J; MULHOLLAND, EK; Kirkwood, CD; Fox, KK; Bines, JE; Grabovac, V; Khan, AS; Kama, M; Russell, FM;
2020
The Lancet regional health. Western Pacific, (2020).6, 10.1016/j.lanwpc.2020.100053.
Building momentum for malaria vaccine research and development: key considerations.
Chitnis, CE; SCHELLENBERG, D; Vekemans, J; Asturias, EJ; Bejon, P; Collins, KA; Crabb, BS; Herrera, S; Laufer, M; Rabinovich, NR; Roestenberg, M; Shearley, A; Tinto, H; Wentworth, M; O'Brien, K; Alonso, P;
2020
Malaria journal, (2020).19 1 10.1186/s12936-020-03491-3.
The predicted impact of tuberculosis preventive therapy: the importance of disease progression assumptions.
SUMNER, T; WHITE, RG;
2020
BMC INFECTIOUS DISEASES, (2020).20 1 10.1186/s12879-020-05592-5.
Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis.
Reyburn, R; Tuivaga, E; Nguyen, CD; Ratu, FT; Nand, D; Kado, J; Tikoduadua, L; Jenkins, K; De Campo, M; Kama, M; Devi, R; Rafai, E; Weinberger, DM; MULHOLLAND, EK; Russell, FM;
2020
The Lancet. Global health, (2020).9 1 10.1016/S2214-109X(20)30421-6.
Economic evaluation of the introduction of rotavirus vaccine in Hong Kong.
Yeung, KH T; Lin, SL; CLARK, A; McGhee, SM; Janusz, CB; Atherly, D; Chan, KC; Nelson, EA S;
2020
Vaccine, (2020).39 1 10.1016/j.vaccine.2020.10.052.
Optimising dengue pre-vaccination screening.
WILDER-SMITH, A; PEELING, RW;
2020
The Lancet. Infectious diseases, (2020).21 4 10.1016/s1473-3099(20)30722-2.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.
Uyoga, S; ADETIFA, IM O; Karanja, HK; Nyagwange, J; Tuju, J; Wanjiku, P; Aman, R; Mwangangi, M; Amoth, P; Kasera, K; Ng'ang'a, W; Rombo, C; Yegon, C; Kithi, K; Odhiambo, E; Rotich, T; Orgut, I; Kihara, S; OTIENDE, M; BOTTOMLEY, C; Mupe, ZN; Kagucia, EW; GALLAGHER, KE; Etyang, A; VOLLER, S; ... Warimwe, GM.
2020
Science, (2020).371 6524 10.1126/science.abe1916.
Co-production of an educational package for the universal human papillomavirus (HPV) vaccination programme tailored for schools with low uptake: a participatory study protocol.
Fisher, H; Audrey, S; CHANTLER, T; Finn, A; Letley, L; MOUNIER-JACK, S; Thomas, C; Yates, J; Hickman, M;
2020
BMJ open, (2020).10 11 10.1136/bmjopen-2020-039029.